During economic recessions, overall public health improves. Sounds wrong, right?
Well, think about it. Less work , less stress. Less people die, fewer heart attacks are reported and general morbidity decreases, according to research from the World Health Organization.
On the other hand, a recent study from the University of Georgia shows that mental illness might be increased during recessions. Researchers say anti-depressant and anti-anxiety drug prescriptions increase during periods of economic recession, mainly in the Northeast region of the U.S.
“We see healthier outcomes for the most part, except for mental health,” said David Bradford, from UGA’s School of Public and International Affairs.
“A large part of the cost of recession is risk, and risk in and of itself can make people depressed and cause stress,” said Bill Lastrapes, an economics professor who also worked on the study.
Anxiety and Depression Increase
Lastrapes and Bradford looked at the relationship between unemployment rates and the prescribing of drugs used to treat mental illness during three recessions, with the largest being the Great Recession from December 2007 through June 2009.
During recessions when unemployment rises and employment falls, prescriptions for anti-depressants and anti-anxiety medications rise, according to the study.
In the Northeast, a 1 percentage point increase in unemployment led to a 10 percent increase in the number of anti-depressant or anti-anxiety drug prescriptions.
“Unemployment rates in the U.S. exceeded 10 percent during the Great Recession, but that means 90 percent of the labor force was still working. So, people were not necessarily depressed because they didn’t have a job, but maybe because they were afraid of getting laid off,” Lastrapes said.
“We are talking about effects too large to be explained by just those losing their jobs, which suggests recessions have a significant impact much broader than those directly affected by the job loss,” Bradford said.
Researchers noted insurance rates were slightly higher in the Northeast, 90 percent, compared to 83 and 84 percent in the South and West but were only slightly higher than the Midwest.
The increase in medical coverage could have an impact on the number of people seeking medical help and ultimately receiving prescriptions for depression.
“At this juncture, though, our data are not detailed enough to explain what drives our findings,” Lastrapes said. “Ultimately, we want to understand how the economy affects the demand for mental health drugs at the ‘micro’ level.”
Bradford and Lastrapes are now looking at data from individuals. They hope to more completely learn about why mental health drug use might be related to job market status and recessions, and what might cause this relationship to differ across individuals.
“There is this spillover effect and that’s why we are looking at individual data. Recessions have a larger impact than just worrying about the folks who lose their jobs,” Bradford said.
“There are negative impacts on other people as well. And we need to understand what those are and hopefully come up with policies to help mitigate them.”